Kura Oncology (KURA) Depreciation and Depletion (2014 - 2026)

Kura Oncology (KURA) has 12 years of Depreciation and Depletion data on file, last reported at $355000.0 in Q1 2026.

• On a quarterly basis, Depreciation and Depletion rose 47.3% year-over-year to $355000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 38.04% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 25.0% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $355000.0, down from $371000.0 in the prior quarter.
• Over the last five years, Depreciation and Depletion for KURA reached as high as $371000.0 in Q4 2025 and fell as low as $156000.0 in Q4 2024.
• Historically, Depreciation and Depletion has averaged $221352.9 across 5 years, with a median of $208000.0 in 2024.
• Across the five-year window, Depreciation and Depletion declined 27.1% in 2024 and jumped 137.82% in 2025, its largest moves.
• Year by year, Depreciation and Depletion stood at $206000.0 in 2022, then rose by 3.88% to $214000.0 in 2023, then declined by 27.1% to $156000.0 in 2024, then soared by 137.82% to $371000.0 in 2025, then retreated by 4.31% to $355000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $355000.0 in Q1 2026, $371000.0 in Q4 2025, and $164000.0 in Q3 2025.